Aarkstore - Epstein-Barr Viral Infections - Pipeline Review, H2 2014

1
Aarkstore - Epstein-Barr Viral Infections -
Pipeline Review, H2 2014
www.aarkstore.com
2
Summary

• Epstein-Barr Viral Infections - Pipeline Review,
  H2 2014, provides an overview of
• the Epstein-Barr Viral Infectionss therapeutic
  pipeline.
• This Market Research Report provides
  comprehensive information on the therapeutic
• development for Epstein-Barr Viral Infections,
  complete with comparative analysis at various
• stages, therapeutics assessment by drug target,
  mechanism of action (MoA), route of
• administration (RoA) and molecule type, along
  with latest updates, and featured news and
• press releases. It also reviews key players
  involved in the therapeutic development for
• Epstein-Barr Viral Infections and special
  features on late-stage and discontinued
  projects.

www.aarkstore.com
www.aarkstore.com
3
Scope

• - The report provides a snapshot of the
  global therapeutic landscape of Epstein-Barr
  Viral Infections- The report reviews key
  pipeline products under drug profile section
  which includes, product description, MoA and RD
  brief, licensing and collaboration details
  other developmental activities - The report
  reviews key players involved in the therapeutics
  development for Epstein-Barr Viral Infections and
  enlists all their major and minor projects- The
  report summarizes all the dormant and
  discontinued pipeline projects - A review of the
  Epstein-Barr Viral Infections products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources- Pipeline
  products coverage based on various stages of
  development ranging from pre-registration till
  discovery and undisclosed stages- A detailed
  assessment of monotherapy and combination therapy
  pipeline projects- Coverage of the Epstein-Barr
  Viral Infections pipeline on the basis of target,
  MoA, route of administration and molecule type-
  Latest news and deals relating related to
  pipeline products

www.aarkstore.com
www.aarkstore.com
4
Reasons to buy

• - Provides strategically significant
  competitor information, analysis, and insights to
  formulate effective RD development strategies-
  Identify emerging players with potentially strong
  product portfolio and create effective
  counter-strategies to gain competitive
  advantage- Develop strategic initiatives by
  understanding the focus areas of leading
  companies- Identify and understand important and
  diverse types of therapeutics under development
  for Epstein-Barr Viral Infections- Plan mergers
  and acquisitions effectively by identifying key
  players of the most promising pipeline- Devise
  corrective measures for pipeline projects by
  understanding Epstein-Barr Viral Infections
  pipeline depth and focus of Indication
  therapeutics- Develop and design in-licensing
  and out-licensing strategies by identifying
  prospective partners with the most attractive
  projects to enhance and expand business potential
  and Scope- Modify the therapeutic portfolio by
  identifying discontinued projects and
  understanding the factors that drove them from
  pipeline

www.aarkstore.com
www.aarkstore.com
5
Table of Contents

• Introduction 6Global Markets Direct
  Report Coverage 6Epstein-Barr Viral Infections
  Overview 7Therapeutics Development 8Pipeline
  Products for Epstein-Barr Viral Infections -
  Overview 8Pipeline Products for Epstein-Barr
  Viral Infections - Comparative Analysis
  9Epstein-Barr Viral Infections - Therapeutics
  under Development by Companies 10Epstein-Barr
  Viral Infections - Therapeutics under
  Investigation by Universities/Institutes
  11Epstein-Barr Viral Infections - Pipeline
  Products Glance 13Clinical Stage Products
  13Early Stage Products 14Epstein-Barr Viral
  Infections - Products under Development by
  Companies 15Epstein-Barr Viral Infections -
  Products under Investigation by
  Universities/Institutes 16

www.aarkstore.com
www.aarkstore.com
6
List Of Tables

• Number of Products under Development for
  Epstein-Barr Viral Infections, H2 2014 8Number
  of Products under Development for Epstein-Barr
  Viral Infections - Comparative Analysis, H2 2014
  9Number of Products under Development by
  Companies, H2 2014 10Number of Products under
  Investigation by Universities/Institutes, H2 2014
  12Comparative Analysis by Clinical Stage
  Development, H2 2014 13Comparative Analysis by
  Early Stage Development, H2 2014 14Products
  under Development by Companies, H2 2014
  15Products under Investigation by
  Universities/Institutes, H2 2014 16Epstein-Barr
  Viral Infections - Pipeline by Cell Medica
  Limited, H2 2014 17Epstein-Barr Viral Infections
  - Pipeline by Conkwest, Inc., H2 2014
  18

www.aarkstore.com
7
List Of Figures

• Number of Products under Development for
  Epstein-Barr Viral Infections, H2 2014Number of
  Products under Development for Epstein-Barr Viral
  Infections - Comparative Analysis, H2 2014Number
  of Products under Development by Companies, H2
  2014 Number of Products under Investigation by
  Universities/Institutes, H2 2014 Comparative
  Analysis by Clinical Stage Development, H2 2014
  Comparative Analysis by Early Stage Products, H2
  2014 Assessment by Monotherapy Products, H2 2014
  Number of Products by Top 10 Targets, H2 2014
  Number of Products by Stage and Top 10 Targets,
  H2 2014 Number of Products by Top 10 Mechanism
  of Actions, H2 2014

www.aarkstore.com
8
Related Market Research reports

• Blirt S.A. - Product Pipeline Review 2014
• Auris Medical Holding AG - Product Pipeline
  Review 2014
• Integral Molecular, Inc. - Product Pipeline
  Review 2014
• DaVinci Biosciences, LLC - Product Pipeline
  Review 2014
• Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports

• TiGenix NV - Product Pipeline Review 2014
• Egenix, Inc. - Product Pipeline Review 2014
• SkyePharma PLC - Product Pipeline Review 2014
• MediWound Ltd. - Product Pipeline Review 2014
• BioTech Tools s.a. - Product Pipeline Review -
  2014

www.aarkstore.com
10
Aarkstore - Epstein-Barr Viral Infections -
Pipeline Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953
• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog http//www.aarkstore.com/blog/
• Conference http//conference.aarkstore.com/
• News http//www.aarkstore.com/news

www.aarkstore.com